The $60 billion biotech Regeneron specializes in making antibody treatments to fight diseases. Top execs just said a potent cocktail to treat the coronavirus could be ready by the end of summer. (REGN)

8:44am PDT - May 5th, 2020    ebola - Business Insider

• The $60 billion biotech Regeneron is aiming to have an experimental antibody cocktail ready for potential emergency use by the end of this summer, the company's executives said Tuesday. 
• Regeneron, a leader of the biotech industry, specializ…